Please select the option that best describes you:
Topics:
Hepatology • Viral Hepatitis
In patients with hepatitis B and co-infection with hepatitis D, given their increased risk of development of HCC, how do you approach screening for this?
What other management considerations are on your mind in such patients?
Answer from: at Academic Institution
Screening frequency is based on tumor-doubling size and not risk of HCC. Every 6 months, imaging is recommended + AFP. HDV patients should be screened if advanced fibrosis (F3-4) is present or VCTE > 9 kPA.
Sign In or Register to read more